MAI Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.7M | Buy |
71,216
+10,177
| +17% | +$4.89M | 0.13% | 146 |
|
|
2026
Q1 | $30M | Buy |
61,039
+1,837
| +3% | +$997K | 0.17% | 119 |
|
|
2025
Q4 | $34.3M | Buy |
59,202
+8,177
| +16% | +$4.62M | 0.2% | 106 |
|
|
2025
Q3 | $24.7M | Buy |
51,025
+7,868
| +18% | +$3.66M | 0.15% | 124 |
|
|
2025
Q2 | $17.5M | Buy |
43,157
+3,580
| +9% | +$1.5M | 0.12% | 153 |
|
|
2025
Q1 | $19.7M | Buy |
39,577
+17,071
| +76% | +$9.25M | 0.15% | 133 |
|
|
2024
Q4 | $11.7M | Buy |
22,506
+8,222
| +58% | +$4.52M | 0.09% | 194 |
|
|
2024
Q3 | $8.84M | Sell |
14,284
-769
| -5% | -$455K | 0.08% | 182 |
|
|
2024
Q2 | $8.32M | Buy |
15,053
+86
| +0.6% | +$49.3K | 0.08% | 191 |
|
|
2024
Q1 | $8.7M | Buy |
14,967
+8,421
| +129% | +$4.73M | 0.09% | 179 |
|
|
2023
Q4 | $3.47M | Buy |
6,546
+174
| +3% | +$84.2K | 0.05% | 242 |
|
|
2023
Q3 | $3.23M | Sell |
6,372
-537
| -8% | -$286K | 0.05% | 234 |
|
|
2023
Q2 | $3.6M | Sell |
6,909
-339
| -5% | -$183K | 0.05% | 224 |
|
|
2023
Q1 | $4.18M | Buy |
7,248
+387
| +6% | +$218K | 0.07% | 205 |
|
|
2022
Q4 | $3.78M | Buy |
6,861
+615
| +10% | +$326K | 0.06% | 204 |
|
|
2022
Q3 | $3.17M | Buy |
6,246
+644
| +11% | +$360K | 0.06% | 209 |
|
|
2022
Q2 | $3.04M | Buy |
5,602
+129
| +2% | +$71K | 0.06% | 198 |
|
|
2022
Q1 | $3.23M | Buy |
5,473
+874
| +19% | +$502K | 0.05% | 202 |
|
|
2021
Q4 | $3.07M | Buy |
4,599
+785
| +21% | +$490K | 0.05% | 216 |
|
|
2021
Q3 | $2.18M | Buy |
3,814
+545
| +17% | +$299K | 0.04% | 222 |
|
|
2021
Q2 | $1.65M | Sell |
3,269
-31
| -0.9% | -$14.6K | 0.03% | 268 |
|
|
2021
Q1 | $1.51M | Buy |
3,300
+463
| +16% | +$221K | 0.03% | 267 |
|
|
2020
Q4 | $1.32M | Buy |
2,837
+235
| +9% | +$110K | 0.03% | 271 |
|
|
2020
Q3 | $1.15M | Sell |
2,602
-28
| -1% | -$11.6K | 0.03% | 255 |
|
|
2020
Q2 | $953K | Buy |
2,630
+10
| +0.4% | +$3.35K | 0.03% | 290 |
|
|
2020
Q1 | $743K | Buy |
2,620
+104
| +4% | +$32.8K | 0.03% | 305 |
|
|
2019
Q4 | $817K | Buy |
2,516
+230
| +10% | +$69.7K | 0.03% | 330 |
|
|
2019
Q3 | $666K | Buy |
2,286
+18
| +0.8% | +$5.15K | 0.03% | 309 |
|
|
2019
Q2 | $666K | Sell |
2,268
-13
| -0.6% | -$3.58K | 0.03% | 311 |
|
|
2019
Q1 | $624K | Sell |
2,281
-389
| -15% | -$96.8K | 0.03% | 275 |
|
|
2018
Q4 | $598K | Sell |
2,670
-5
| -0.2% | -$1.17K | 0.03% | 280 |
|
|
2018
Q3 | $653K | Buy |
2,675
+16
| +0.6% | +$3.68K | 0.03% | 277 |
|
|
2018
Q2 | $551K | Sell |
2,659
-239
| -8% | -$50.7K | 0.03% | 288 |
|
|
2018
Q1 | $598K | Sell |
2,898
-15
| -0.5% | -$3.15K | 0.03% | 276 |
|
|
2017
Q4 | $553K | Buy |
2,913
+5
| +0.2% | +$958 | 0.03% | 285 |
|
|
2017
Q3 | $550K | Buy |
2,908
+139
| +5% | +$25.2K | 0.03% | 267 |
|
|
2017
Q2 | $483K | Sell |
2,769
-518
| -16% | -$87K | 0.03% | 280 |
|
|
2017
Q1 | $505K | Buy |
3,287
+1,381
| +72% | +$211K | 0.03% | 260 |
|
|
2016
Q4 | $269K | Hold |
1,906
| – | – | 0.02% | 354 |
|
|
2016
Q3 | $303K | Hold |
1,906
| – | – | 0.02% | 334 |
|
|
2016
Q2 | $282K | Hold |
1,906
| – | – | 0.02% | 331 |
|
|
2016
Q1 | $270K | Hold |
1,906
| – | – | 0.02% | 335 |
|
|
2015
Q4 | $270K | Sell |
1,906
-89
| -4% | -$11.9K | 0.02% | 339 |
|
|
2015
Q3 | $244K | Sell |
1,995
-129
| -6% | -$16.8K | 0.02% | 370 |
|
|
2015
Q2 | $276K | Hold |
2,124
| – | – | 0.02% | 380 |
|
|
2015
Q1 | $285K | Hold |
2,124
| – | – | 0.02% | 389 |
|
|
2014
Q4 | $266K | Buy |
2,124
+98
| +5% | +$11.9K | 0.02% | 381 |
|
|
2014
Q3 | $247K | Buy |
2,026
+101
| +5% | +$12.3K | 0.02% | 333 |
|
|
2014
Q2 | $227K | Hold |
1,925
| – | – | 0.02% | 349 |
|
|
2014
Q1 | $231K | Sell |
1,925
-214
| -10% | -$25.4K | 0.02% | 347 |
|
|
2013
Q4 | $238K | Buy |
+2,139
| New | +$213K | 0.03% | 320 |
|
|
2013
Q3 | – | Sell |
-2,504
| Closed | -$212K | – | 363 |
|
|
2013
Q2 | $212K | Buy |
+2,504
| New | +$208K | 0.03% | 282 |
|
Other funds holding TMO
MAI Capital Management's TMO Position: Q2 2026 in Review
MAI Capital Management increased its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, buying an estimated $4.89M and bringing the position to 71,216 shares worth $35.7M. The position accounts for 0.13% of the portfolio, ranked #146.
MAI Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- MAI Capital Management held 71,216 shares of Thermo Fisher Scientific worth $35.7M as of Q2 2026.
- MAI Capital Management bought 10,177 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.89M.
- Thermo Fisher Scientific made up 0.13% of MAI Capital Management's portfolio in Q2 2026, its #146 holding.
- MAI Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- 2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.